Akkermansia muciniphila: The role as a probiotic bacteria for the prevention and treatment of metabolic syndrome

Metabolic syndrome is a health problem triggered by several metabolic parameters, which are common in the mexican population as well as worldwide, and which is often not treated globally but rather individually for each of these aspects. This review aims to present the different mechanisms and effects of probiotic bacteria for the prevention or treatment of MetS as a natural therapeutic alternative. The role of the intestinal microbiota in human health is crucial, and alterations in its abundance and composition are believed to be related to multiple diseases. Numerous studies have shown a strong association between certain microorganisms and diseases such as obesity, inflammatory diseases, type 2 diabetes mellitus, different types of cancer and neurodegenerative diseases Akkermansia muciniphila increases intestinal mucosal thicknesss and produces hort-chain fatty acids that may play an important role in the health and inflammatory status of the host. The Akkermansia muciniphila bacteria turns out to be a very promising probiotic for the treatment or prevention of many diseases, but especially those resulting in metabolic disorders or metabolic syndrome, and the supplementation along with a low-calorie diet and functional food, it could favor the amount of this bacteria in large intestine and its reproduction.